4.7 Article

Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari-Goldstein Relaxations

期刊

出版社

MDPI
DOI: 10.3390/ijms23052456

关键词

amorphous pharmaceuticals; polymer enantiomerism; Valium metabolite; formulation morphology; glass transition; dielectric spectroscopy; molecular mobility; secondary relaxations

向作者/读者索取更多资源

In this study, dispersions of a small-molecule drug in biodegradable polylactide were investigated using differential scanning calorimetry and broadband dielectric spectroscopy. The study reveals that the same small-molecule compound can have opposite effects on the mobility of a biopolymer depending on the preparation method, temperature, and polymer enantiomerism. The drug acts as an antiplasticizer for films but as a plasticizer for microfibres. Furthermore, the structural relaxation time of the samples is influenced by the chemical composition and morphology.
Amorphous molecule-macromolecule mixtures are ubiquitous in polymer technology and are one of the most studied routes for the development of amorphous drug formulations. For these applications it is crucial to understand how the preparation method affects the properties of the mixtures. Here, we employ differential scanning calorimetry and broadband dielectric spectroscopy to investigate dispersions of a small-molecule drug (the Nordazepam anxiolytic) in biodegradable polylactide, both in the form of solvent-cast films and electrospun microfibres. We show that the dispersion of the same small-molecule compound can have opposite (plasticizing or antiplasticizing) effects on the segmental mobility of a biopolymer depending on preparation method, temperature, and polymer enantiomerism. We compare two different chiral forms of the polymer, namely, the enantiomeric pure, semicrystalline L-polymer (PLLA), and a random, fully amorphous copolymer containing both L and D monomers (PDLLA), both of which have lower glass transition temperature (T-g) than the drug. While the drug has a weak antiplasticizing effect on the films, consistent with its higher T-g, we find that it actually acts as a plasticizer for the PLLA microfibres, reducing their T-g by as much as 14 K at 30%-weight drug loading, namely, to a value that is lower than the T-g of fully amorphous films. The structural relaxation time of the samples similarly depends on chemical composition and morphology. Most mixtures displayed a single structural relaxation, as expected for homogeneous samples. In the PLLA microfibres, the presence of crystalline domains increases the structural relaxation time of the amorphous fraction, while the presence of the drug lowers the structural relaxation time of the (partially stretched) chains in the microfibres, increasing chain mobility well above that of the fully amorphous polymer matrix. Even fully amorphous homogeneous mixtures exhibit two distinct Johari-Goldstein relaxation processes, one for each chemical component. Our findings have important implications for the interpretation of the Johari-Goldstein process as well as for the physical stability and mechanical properties of microfibres with small-molecule additives.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据